Annual report
6823.TEDINET S100YI2O
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥28.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥25.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥4.4bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.4bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.6bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.4bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.9bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.2bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥41.8bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥39.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥37.1bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥34.6bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥33.2bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥34.8bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥31.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥29.2bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥26.6bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥25.3bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.2bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.9bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥753m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥952m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥955m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥749m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥566m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥577m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥542m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥271.41 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥215.51 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.33 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.41 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,822.57 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,551.75 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,372.88 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,163.3 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,057.4 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 83.3% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,003 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,009 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,026 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 998 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 954 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥23.1bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥22.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥21.0bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.5bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.2bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.7bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥3.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.2bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.2bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.2bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥3.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥38.5bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥37.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥34.3bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.7bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥29.9bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.5bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥7.6bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥32.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥29.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥26.9bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥24.0bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥23.0bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.3bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥262.96 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥269.12 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥278.19 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥129.53 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.29 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥85 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,596.02 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,390.82 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,188.6 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,954.68 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,872.33 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.1% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.5% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.4% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 12,347,700 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,336,700 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,327,900 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,319,100 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,309,100 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 499 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 504 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 508 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 495 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 504 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥35m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥88m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥11.9bn |
| Environmental Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥147m |
| Environmental Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥259m |
| Environmental Equipmentreportable segment | employees | at 2026-03-31 | 170 pure |
| Environmental Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥6.0bn |
| Environmental Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥6.0bn |
| Environmental Equipmentreportable segment | segment assets | at 2026-03-31 | ¥7.3bn |
| Environmental Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥734m |
| Medical Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥253m |
| Medical Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥527m |
| Medical Equipmentreportable segment | employees | at 2026-03-31 | 550 pure |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥12.8bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥12.8bn |
| Medical Equipmentreportable segment | segment assets | at 2026-03-31 | ¥11.3bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Particle Countersreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥190m |
| Particle Countersreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥458m |
| Particle Countersreportable segment | employees | at 2026-03-31 | 182 pure |
| Particle Countersreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥9.7bn |
| Particle Countersreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥9.7bn |
| Particle Countersreportable segment | segment assets | at 2026-03-31 | ¥11.3bn |
| Particle Countersreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.4bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥590m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥28.5bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥28.5bn |
| —segment total | segment assets | at 2026-03-31 | ¥29.9bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥4.4bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥142m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥88m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥9.1bn |
| Environmental Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥296m |
| Environmental Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥246m |
| Environmental Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥5.8bn |
| Environmental Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥5.8bn |
| Environmental Equipmentreportable segment | segment assets | at 2025-03-31 | ¥7.1bn |
| Environmental Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥164m |
| Medical Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥612m |
| Medical Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥456m |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-03-31 | ¥11.5bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Particle Countersreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥565m |
| Particle Countersreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥384m |
| Particle Countersreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥9.5bn |
| Particle Countersreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥9.5bn |
| Particle Countersreportable segment | segment assets | at 2025-03-31 | ¥11.5bn |
| Particle Countersreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥27.9bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥27.9bn |
| —segment total | segment assets | at 2025-03-31 | ¥30.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Environmental Equipmentreportable segment | employees | at 2026-03-31 | 119 pure |
| Medical Equipmentreportable segment | employees | at 2026-03-31 | 195 pure |
| Particle Countersreportable segment | employees | at 2026-03-31 | 133 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,566
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent assets | CurrentYearInstant | 16652077000 | JPY |
| Assets | Prior1YearInstant | 39132557000 | JPY |
| Assets | CurrentYearInstant | 41784051000 | JPY |
| Accounts payable cl | Prior1YearInstant | 2250020000 | JPY |
| Accounts payable cl | CurrentYearInstant | 1643928000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 46704000 | JPY |
| Electronically recorded obligations operating cl | CurrentYearInstant | 30577000 | JPY |
| Accrued expenses | Prior1YearInstant | 395462000 | JPY |
| Accrued expenses | CurrentYearInstant | 361459000 | JPY |
| Income taxes payable | Prior1YearInstant | 824871000 | JPY |
| Income taxes payable | CurrentYearInstant | 642589000 | JPY |
| Accrued consumption taxes | Prior1YearInstant | 24455000 | JPY |
| Accrued consumption taxes | CurrentYearInstant | 22797000 | JPY |
| Contract liabilities cl | Prior1YearInstant | 68568000 | JPY |
| Contract liabilities cl | CurrentYearInstant | 121351000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1243575000 | JPY |
| Provision for bonuses | CurrentYearInstant | 1289149000 | JPY |
| Provision for product warranties | Prior1YearInstant | 251785000 | JPY |
| Provision for product warranties | CurrentYearInstant | 297545000 | JPY |
| Other cl | Prior1YearInstant | 349413000 | JPY |
| Other cl | CurrentYearInstant | 218778000 | JPY |
| Current liabilities | Prior1YearInstant | 5454857000 | JPY |
| Current liabilities | CurrentYearInstant | 4628179000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 58047000 | JPY |
| Deferred tax liabilities | CurrentYearInstant | 60188000 | JPY |
| Deferred tax liabilities for land revaluation | Prior1YearInstant | 1477637000 | JPY |
| Deferred tax liabilities for land revaluation | CurrentYearInstant | 1477637000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 506635000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 619151000 | JPY |
| Other ncl | Prior1YearInstant | 199608000 | JPY |
| Other ncl | CurrentYearInstant | 195680000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 2241928000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 2352657000 | JPY |
| Liabilities | Prior1YearInstant | 7696786000 | JPY |
| Liabilities | CurrentYearInstant | 6980836000 | JPY |
| Capital stock | Prior1YearInstant | 2064899000 | JPY |
| Capital stock | CurrentYearInstant | 2079254000 | JPY |
| Capital surplus | Prior1YearInstant | 2488397000 | JPY |
| Capital surplus | CurrentYearInstant | 2502752000 | JPY |
| Retained earnings | Prior1YearInstant | 22549374000 | JPY |
| Retained earnings | CurrentYearInstant | 24946037000 | JPY |
| Treasury stock | Prior1YearInstant | -10728000 | JPY |
| Treasury stock | CurrentYearInstant | -10728000 | JPY |
| Shareholders equity | Prior1YearInstant | 27091944000 | JPY |
| Shareholders equity | CurrentYearInstant | 29517316000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 480787000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 716209000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | 3207031000 | JPY |
| Revaluation reserve for land | CurrentYearInstant | 3207031000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -42443000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |